Frequently asked questions about BioAFM

Do you have a question about BioAFM? This article will tell you everything you need to know.

FDA grants fast track status to Rznomics’ RZ-001 drug for HCC

The drug is currently undergoing Phase Ib/IIa trials for hepatocellular carcinoma. Credit: SewCreamStudio/Shutterstock. The US Food and Drug Administration (FDA) has granted fast track designation

February 18, 2025

Private equity investment in Medicare Advantage drops

Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing in Medicare Advantage, according to a new report. But investors

February 13, 2024

Why do some people need supplements and others don’t? New review explains

New research in The New England Journal of Medicine reviews current knowledge on micronutrient requirements, deficiencies, and interventions. It highlights the need for targeted supplementation

March 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.